The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice

Ahlgren, 1994, Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in streptozotocin-diabetic rat, J. Neurophysiol., 72, 684, 10.1152/jn.1994.72.2.684 Antunes Bras, 1999, Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cord, J. Neurochem., 72, 858, 10.1046/j.1471-4159.1999.720858.x Bian, 1991, Identification of intracellular Ca2+ pools. Selective modification by thapsigargin, J. Biol. Chem., 266, 8801, 10.1016/S0021-9258(18)31518-7 Breukel, 1998, Presynaptic modulation of cholecystokinin release by protein kinase C in the rat hippocampus, J. Neurochem., 70, 341, 10.1046/j.1471-4159.1998.70010341.x Coudore-Civiale, 2000, Potentiation of morphine and clomipramine analgesia by cholecystokinin-B antagonist CI-988 in diabetic rats, Neurosci. Lett., 26, 37, 10.1016/S0304-3940(00)01080-6 Courteix, 1993, Streptozotocin-induced diabetic rats: behavioural evidence for a model of chronic pain, Pain, 53, 81, 10.1016/0304-3959(93)90059-X Friel, 1992, A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog sympathetic neurons modulates effects of Ca2+ entry on [Ca2+], J. Physiol., 450, 217, 10.1113/jphysiol.1992.sp019125 Hattori, 1994, Attenuated contractile response of diabetic rat aorta to caffeine but not to noradrenaline in Ca2+-free medium, Eur. J. Pharmacol., 256, 215, 10.1016/0014-2999(94)90249-6 Hayes, 1992, Pre-treatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathy, Pain, 48, 391, 10.1016/0304-3959(92)90089-T Hylden, 1980, Intrathecal morphine in mice: a new technique, Eur. J. Pharmacol., 67, 313, 10.1016/0014-2999(80)90515-4 Kamei, 1991, Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not for thermal stimuli, Pharmacol. Biochem. Behav., 39, 541, 10.1016/0091-3057(91)90224-P Kaufmann, 1993, Studies with succinylated CCK-4 derivatives: Characterization of CCKB receptor binding and measurement of [Ca2+]i mobilization, Mol. Neuropharmacol., 3, 147 Kovelowski, 2000, Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat, Pain, 87, 265, 10.1016/S0304-3959(00)00290-6 Mao, 1992, Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury, Brain Res., 588, 144, 10.1016/0006-8993(92)91354-H McPherson, 1991, The brain ryanodine receptor: Caffeine-sensitive Ca2+ release channel, Neuron, 7, 17, 10.1016/0896-6273(91)90070-G Miyoshi, 1991, Cholecystokinin increases intracellular Ca2+ concentration in cultured striatal neurons, Neuropeptides, 18, 115, 10.1016/0143-4179(91)90102-O Nagase, 1991, Effect of cholecystokinin-8 on the intracellular Ca2+ concentration in GH3, a rat anterior pituitary cell line, Jpn. J. Pharmacol., 55, P115, 10.1016/S0021-5198(19)38355-6 Narita, 1997, Pre-treatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ- but not ε-opioid receptor agonist in the mouse, Neuroscience, 76, 291, 10.1016/S0306-4522(96)00354-5 Ohsawa, 1997, Possible involvement of protein kinase C in the attenuation of DAMGO-induced antinociception in diabetic mice, Eur. J. Pharmacol., 339, 27, 10.1016/S0014-2999(97)01365-4 Ohsawa, 1999, Possible involvement of spinal protein kinase C in the thermal allodynia and hyperalgesia in diabetic mice, Eur. J. Pharmacol., 372, 221, 10.1016/S0014-2999(99)00228-9 Ohsawa, 1999, Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice, Brain Res., 833, 278, 10.1016/S0006-8993(99)01506-1 Stanfa, 1994, Cholecystokinin and morphine analgesia: variations on a theme, Trends Pharmacol. Sci., 15, 65, 10.1016/0165-6147(94)90279-8 Vaccarino, 1987, Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons, Proc. Natl. Acad. Sci. USA, 84, 8707, 10.1073/pnas.84.23.8707 Wang, 1992, Mobilization of calcium from intracellular stores as one of the mechanisms underlying the antiopioid effect of cholecystokinin octapeptide, Peptides, 13, 947, 10.1016/0196-9781(92)90054-7 Yamamoto, 1999, Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat, Anesthesiology, 90, 1382, 10.1097/00000542-199905000-00023 Yeomans, 1996, Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence, Pain, 68, 141, 10.1016/S0304-3959(96)03177-6 Yeomans, 1996, Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence, Pain, 68, 133, 10.1016/S0304-3959(96)03176-4 Yu, 1994, Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding, Am. J. Physiol., 266, H2082 Zouaoui, 1990, Cholecystokinin-like immunoreactivity in the dorsal horn of the rat spinal cord: an attempt to analyse contradictory results between immunocytochemistry and radioimmunoassay, Neuropeptides, 17, 177, 10.1016/0143-4179(90)90033-U